All Stories

  1. Association between Birt-Hogg-Dubé syndrome and Pulmonary Hypertension: a case series

    Article • ERJ Open Research, July 2026, European Respiratory Society (ERS)

    Professor Olivier SITBON

  2. Placental Growth Factor Promotes Endothelial Activation and Inflammatory Remodelling in Pulmonary Hypertension

    Article • Cardiovascular Research, July 2026, Oxford University Press (OUP)

    Professor Olivier SITBON

  3. Effective Arterial Elastance Relates More Closely to Pulsatile Than Resistive Indices During Routine Hemodynamic Assessment of Inoperable CTEPH

    Article • ERJ Open Research, May 2026, European Respiratory Society (ERS)

    Professor Olivier SITBON

  4. Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial Hypertension

    Article • American Review of Respiratory Disease, May 2026, Oxford University Press (OUP)

    Professor Olivier SITBON

  5. Multimodal investigation of the association between bevacizumab and pulmonary arterial hypertension

    Article • ERJ Open Research, April 2026, European Respiratory Society (ERS)

    Professor Olivier SITBON

  6. Bridging Disciplines in Portopulmonary Hypertension: A Multidisciplinary Call for Harmonized Patient Management

    Article • Journal of Hepatology, January 2026, Elsevier

    Professor Olivier SITBON

  7. Chronic thromboembolic pulmonary hypertension associated with venous thoracic outlet syndrome: a retrospective case series

    Article • European Respiratory Journal, November 2025, European Respiratory Society (ERS)

    Professor Olivier SITBON

  8. Correspondence on: Pulmonary arterial hypertension in adults with Still’s disease: another pulmonary manifestation associated with HLA-DRB1*15–reply

    Article • Annals of the Rheumatic Diseases, October 2025, Elsevier

    Professor Olivier SITBON

  9. Response to correspondence on: Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15

    Article • Annals of the Rheumatic Diseases, October 2025, Elsevier

    Professor Olivier SITBON

  10. Safety and Efficacy of upfront triple therapy including parenteral treprostinil compared to double oral therapy in PAH (TripleTRE): study protocol for a randomized trial

    Article • ERJ Open Research, August 2025, European Respiratory Society (ERS)

    Professor Olivier SITBON

  11. Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study

    Article • Advances in Therapy, August 2025, Springer Science + Business Media

    Professor Olivier SITBON

  12. Clustering Patients with Pulmonary Hypertension Using the Plasma Proteome

    Article • American Review of Respiratory Disease, August 2025, American Thoracic Society

    Professor Olivier SITBON

  13. The Activin Pathway in Chronic Thromboembolic Pulmonary Hypertension: A Potential Biomarker for Residual Pulmonary Hypertension After Endarterectomy

    Article • ERJ Open Research, July 2025, European Respiratory Society (ERS)

    Professor Olivier SITBON

  14. Diuretic adherence in patients with precapillary pulmonary hypertension: insights from the PHARE study

    Article • ERJ Open Research, May 2025, European Respiratory Society (ERS)

    Professor Olivier SITBON

  15. Drugs targeting novel pathways in pulmonary arterial hypertension

    Article • European Respiratory Journal, May 2025, European Respiratory Society (ERS)

    Professor Olivier SITBON

  16. Risk stratification in Eisenmenger syndrome

    Article • Archives of Cardiovascular Diseases, May 2025, Elsevier

    Professor Olivier SITBON

  17. ERS Congress 2024: highlights from the Pulmonary Vascular Diseases Assembly

    Article • ERJ Open Research, April 2025, European Respiratory Society (ERS)

    Professor Olivier SITBON

  18. Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in CTEPH: Insights From the RACE Trial

    Article • Circulation Cardiovascular Interventions, February 2025, Wolters Kluwer Health

    Professor Olivier SITBON

  19. Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON study

    Article • The Journal of Heart and Lung Transplantation, December 2024, Elsevier

    Professor Olivier SITBON

  20. Effect of sotatercept on circulating proteomics in pulmonary arterial hypertension

    Article • European Respiratory Journal, September 2024, European Respiratory Society (ERS)

    Professor Olivier SITBON

  21. Thirty years of surgical management of pediatric pulmonary hypertension: Mid-term outcomes following reverse Potts shunt and transplantation

    Article • Journal of Thoracic and Cardiovascular Surgery, September 2024, Elsevier

    Professor Olivier SITBON

  22. Treatment algorithm for pulmonary arterial hypertension

    Article • European Respiratory Journal, August 2024, European Respiratory Society (ERS)

    Professor Olivier SITBON, Professor Zhi-Cheng JING

  23. Medication adherence, related factors and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: a systematic review

    Article • European Respiratory Review, July 2024, European Respiratory Society (ERS)

    Professor Olivier SITBON

  24. Risk Assessment in Pulmonary Veno-Occlusive Disease: The First Step Towards Future Trials?

    Article • Archivos de Bronconeumología (English Edition), July 2024, Elsevier

    Professor Olivier SITBON

  25. Percutaneous atrial septal defect closure in patients with pulmonary arterial hypertension

    Article • European Respiratory Journal, May 2024, European Respiratory Society (ERS)

    Professor Olivier SITBON

  26. POINT: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? Yes

    Article • CHEST Journal, March 2024, Elsevier

    Professor Olivier SITBON

  27. Pulmonary veno-occlusive disease: illustrative cases and literature review

    Article • European Respiratory Review, January 2024, European Respiratory Society (ERS)

    Professor Olivier SITBON

  28. The Management of Pulmonary Arterial Hypertension in the Setting of Systemic Sclerosis

    Article • January 2024, Springer Science + Business Media

    Professor Olivier SITBON

  29. From the microscopic to the macroscopic: clinical–radiological–pathological correlation in pulmonary hypertension

    Article • European Respiratory Review, December 2023, European Respiratory Society (ERS)

    Professor Olivier SITBON

  30. ERS International Congress 2023: highlights from the Pulmonary Vascular Diseases Assembly

    Article • ERJ Open Research, November 2023, European Respiratory Society (ERS)

    Professor Olivier SITBON

  31. Sequential multimodal therapy in chronic thromboembolic pulmonary hypertension with mixed anatomical lesions: a proof of concept

    Article • European Respiratory Journal, October 2023, European Respiratory Society (ERS)

    Professor Olivier SITBON

  32. Pulmonary arterial hypertension

    Article • La Presse Médicale, September 2023, Elsevier

    Professor Olivier SITBON

  33. Diagnosis and management of pulmonary veno-occlusive disease

    Article • Expert Review of Respiratory Medicine, August 2023, Taylor & Francis

    Professor Olivier SITBON

  34. New trends in pulmonary hypertension

    Article • European Respiratory Review, February 2023, European Respiratory Society (ERS)

    Professor Olivier SITBON

  35. Reply to Jha

    Article • American Review of Respiratory Disease, February 2023, American Thoracic Society

    Professor Olivier SITBON

  36. The Influence of Methods for Cardiac Output Determination on the Diagnosis of Precapillary Pulmonary Hypertension: A Mathematical Model

    Article • Journal of Clinical Medicine, January 2023, MDPI AG

    Professor Olivier SITBON

  37. To be or not to be… treated with initial combination therapy, that is the (PAH) question

    Article • European Respiratory Journal, June 2022, European Respiratory Society (ERS)

    Olivier Sitbon, Professor Olivier SITBON

  38. Erythrocytes are altered in pulmonary arterial hypertension

    Article • European Respiratory Journal, May 2022, European Respiratory Society (ERS)

    Professor Olivier SITBON

  39. ERS statement on chronic thromboembolic pulmonary hypertension

    Article • PULMONOLOGIYA, February 2022, Scientific and Practical Reviewed Journal Pulmonology

    Professor Olivier SITBON

  40. Sequential combination therapy with parenteral prostacyclin in BMPR2 mutations carriers

    Article • Pulmonary Circulation, January 2022, Wiley

    Professor Olivier SITBON

  41. Reply to Jin et al. and to Sun et al.

    Article • American Review of Respiratory Disease, December 2021, American Thoracic Society

    Professor Olivier SITBON

  42. Sex and gender in pulmonary arterial hypertension

    Article • European Respiratory Review, November 2021, European Respiratory Society (ERS)

    Professor Olivier SITBON

  43. Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs

    Article • European Respiratory Journal, April 2021, European Respiratory Society (ERS)

    Ari Chaouat, Professor Olivier SITBON

  44. The isobaric pulmonary arterial compliance in pulmonary hypertension

    Article • ERJ Open Research, March 2021, European Respiratory Society (ERS)

    Professor Olivier SITBON

  45. Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?

    Article • American Review of Respiratory Disease, February 2021, American Thoracic Society

    Professor Olivier SITBON

  46. Initial triple therapy in pulmonary arterial hypertension: coming of age and rejuvenated

    Article • European Respiratory Journal, January 2021, European Respiratory Society (ERS)

    Professor Olivier SITBON

  47. Reply to: “Management of portopulmonary hypertension: What is more important, PAH severity or liver disease severity?”

    Article • Journal of Hepatology, January 2021, Elsevier

    Professor Olivier SITBON

  48. ERS statement on chronic thromboembolic pulmonary hypertension

    Article • European Respiratory Journal, December 2020, European Respiratory Society (ERS)

    marion delcroix, Joanna Pepke-Zaba, Professor Olivier SITBON

  49. Reversible pulmonary hypertension associated with multivisceral Whipple's disease

    Article • European Respiratory Journal, October 2020, European Respiratory Society (ERS)

    Professor Olivier SITBON

  50. Long-term outcomes with initial triple oral therapy in pulmonary arterial hypertension (PAH): Insights from TRITON

    Article • September 2020, European Respiratory Society (ERS)

    Professor Olivier SITBON

  51. Pulmonary Hypertension Complicating Pulmonary Artery Involvement in Pseudoxanthoma Elasticum

    Article • American Review of Respiratory Disease, September 2020, American Thoracic Society

    Professor Olivier SITBON

  52. Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors

    Article • European Respiratory Journal, June 2020, European Respiratory Society (ERS)

    Professor Olivier SITBON

  53. Severe Pulmonary Hypertension Management Across Europe (PHAROS): an ERS Clinical Research Collaboration

    Article • European Respiratory Journal, May 2020, European Respiratory Society (ERS)

    Professor Olivier SITBON

  54. Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension

    Article • European Respiratory Journal, April 2020, European Respiratory Society (ERS)

    Professor Olivier SITBON

  55. Transition from intravenous epoprostenol to selexipag in pulmonary arterial hypertension: a word of caution

    Article • European Respiratory Journal, February 2020, European Respiratory Society (ERS)

    Professor Olivier SITBON

  56. Pulmonary arterial hypertension registries: past, present and into the future

    Article • European Respiratory Review, December 2019, European Respiratory Society (ERS)

    Professor Olivier SITBON

  57. Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertension

    Article • European Respiratory Journal, November 2019, European Respiratory Society (ERS)

    Professor Olivier SITBON

  58. A dynamic prognostic model to predict survival and determine treatment goals in pulmonary arterial hypertension (PAH): the EFORT study

    Article • September 2019, European Respiratory Society (ERS)

    Professor Olivier SITBON

  59. Assembly 13: placing the pulmonary circulation in the heart of ERS

    Article • Breathe, March 2019, European Respiratory Society (ERS)

    anton vonk noordegraaf, Professor Olivier SITBON

  60. Highlights from the ERS International Congress 2018: Assembly 13 – Pulmonary Vascular Diseases

    Article • ERJ Open Research, February 2019, European Respiratory Society (ERS)

    Professor Olivier SITBON

  61. Clinical trial design and new therapies for pulmonary arterial hypertension

    Article • European Respiratory Journal, January 2019, European Respiratory Society (ERS)

    Olivier Sitbon, Professor Olivier SITBON

  62. Hépatopathies et maladies vasculaires pulmonaires

    Article • La Revue de Médecine Interne, December 2018, Elsevier

    Professor Olivier SITBON

  63. Clinical and Hemodynamic Correlates of Pulmonary Arterial Stiffness in Incident, Untreated Patients With Idiopathic Pulmonary Arterial Hypertension

    Article • CHEST Journal, October 2018, Elsevier

    Professor Olivier SITBON

  64. Association Between BMI and Obesity With Survival in Pulmonary Arterial Hypertension

    Article • CHEST Journal, October 2018, Elsevier

    Professor Olivier SITBON

  65. Impact of the initiation of balloon pulmonary angioplasty program on referral of patients with chronic thromboembolic pulmonary hypertension to surgery

    Article • The Journal of Heart and Lung Transplantation, September 2018, Elsevier

    Professor Olivier SITBON

  66. Risk stratification in pulmonary arterial hypertension

    Article • Current Opinion in Pulmonary Medicine, September 2018, Wolters Kluwer Health

    Professor Olivier SITBON

  67. Évaluation de l’IRM cardiaque dans le suivi des patients ayant une hypertension artérielle pulmonaire (EVITA). IRM cardiaque dans le suivi de l’hypertension artérielle pulmonaire

    Article • Revue des Maladies Respiratoires, September 2018, Elsevier

    Professor Olivier SITBON

  68. Pulmonary hypertension associated with neurofibromatosis type 1

    Article • European Respiratory Review, August 2018, European Respiratory Society (ERS)

    Professor Olivier SITBON

  69. Natural History over 8 Years of Pulmonary Vascular Disease in a Patient Carrying Biallelic EIF2AK4 Mutations

    Article • American Review of Respiratory Disease, August 2018, American Thoracic Society

    Professor Marc Humbert, Professor Olivier SITBON

  70. Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension

    Article • International Journal of Clinical Pharmacy, August 2018, Springer Science + Business Media

    Professor Olivier SITBON

  71. Portopulmonary hypertension

    Article • July 2018, Oxford University Press (OUP)

    Professor Olivier SITBON

  72. Factors predicting outcome after pulmonary endarterectomy

    Article • PLOS One, June 2018, PLOS

    Professor Olivier SITBON

  73. Genetic determinants of risk and survival in pulmonary arterial hypertension

    Article • May 2018, Cold Spring Harbor Laboratory Press

    Professor Olivier SITBON

  74. Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis

    Article • PLOS One, May 2018, PLOS

    Professor Olivier SITBON

  75. Age, risk and outcomes in idiopathic pulmonary arterial hypertension

    Article • European Respiratory Journal, May 2018, European Respiratory Society (ERS)

    Professor Olivier SITBON

  76. Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease

    Article • The Journal of Heart and Lung Transplantation, May 2018, Elsevier

    Professor Olivier SITBON

  77. The Low-Risk Profile in Pulmonary Arterial Hypertension. Time for a Paradigm Shift to Goal-oriented Clinical Trial Endpoints?

    Article • American Review of Respiratory Disease, April 2018, American Thoracic Society

    Olivier Sitbon, Professor Olivier SITBON

  78. Outcome of Portopulmonary Hypertension After Liver Transplantation

    Article • Transplantation, April 2018, Wolters Kluwer Health

    Professor Olivier SITBON

  79. Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial

    Article • PLOS One, March 2018, PLOS

    Professor Rogerio Souza, Professor Olivier SITBON, Prof Tomas Pulido

  80. Risk assessment in pulmonary arterial hypertension

    Article • European Respiratory Journal, March 2018, European Respiratory Society (ERS)

    Olivier Sitbon, Professor Olivier SITBON

  81. Temporary treatment interruptions with oral selexipag in pulmonary arterial hypertension: Insights from the Prostacyclin (PGI 2 ) Receptor Agonist in Pulmonary Arterial Hypertension (GRIPHON) study

    Article • The Journal of Heart and Lung Transplantation, March 2018, Elsevier

    Professor Olivier SITBON

  82. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension

    Article • Circulation, February 2018, Wolters Kluwer Health

    Professor Olivier SITBON

  83. RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study

    Article • Lung, February 2018, Springer Science + Business Media

    Professor Rogerio Souza, Professor Olivier SITBON

  84. Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality

    Article • Journal of the American College of Cardiology, February 2018, Elsevier

    Professor Rogerio Souza, Professor Olivier SITBON, Prof Tomas Pulido

  85. La maladie veino-occlusive pulmonaire

    Article • Revue des Maladies Respiratoires, February 2018, Elsevier

    Professor Olivier SITBON

  86. Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study

    Article • American Journal of Cardiovascular Drugs, January 2018, Springer Science + Business Media

    Professor Olivier SITBON

  87. Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension Registry

    Article • Respiration, January 2018, Karger Publishers

    Professor Olivier SITBON

  88. Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus

    Article • CHEST Journal, January 2018, Elsevier

    Professor Olivier SITBON

  89. Acute decompensated pulmonary hypertension

    Article • European Respiratory Review, November 2017, European Respiratory Society (ERS)

    Professor Olivier SITBON

  90. Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension

    Article • The Journal of Heart and Lung Transplantation, November 2017, Elsevier

    Professor Olivier SITBON

  91. Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension

    Article • European Respiratory Journal, October 2017, European Respiratory Society (ERS)

    Professor Olivier SITBON

  92. Medical Treatment of Pulmonary Arterial Hypertension

    Article • Seminars in Respiratory and Critical Care Medicine, October 2017, Thieme Publishing Group

    Professor Olivier SITBON

  93. Portopulmonary Hypertension

    Article • Seminars in Respiratory and Critical Care Medicine, October 2017, Thieme Publishing Group

    Professor Olivier SITBON

  94. Exertional dyspnoea in pulmonary arterial hypertension

    Article • European Respiratory Review, September 2017, European Respiratory Society (ERS)

    Professor Olivier SITBON

  95. Are indexed values better for defining exercise pulmonary hypertension?

    Article • European Respiratory Journal, September 2017, European Respiratory Society (ERS)

    Professor Olivier SITBON

  96. Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study

    Article • The Lancet Respiratory Medicine, September 2017, Elsevier

    Professor Olivier SITBON, Professor Allan Lawrie

  97. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

    Article • European Respiratory Journal, August 2017, European Respiratory Society (ERS)

    Olivier Sitbon, Professor Olivier SITBON

  98. Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension

    Article • European Respiratory Journal, August 2017, European Respiratory Society (ERS)

    Sean Gaine, Professor Olivier SITBON

  99. Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension

    Article • The Annals of Thoracic Surgery, August 2017, Elsevier

    Professor Olivier SITBON

  100. Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study

    Article • European Respiratory Journal, July 2017, European Respiratory Society (ERS)

    Professor Olivier SITBON

  101. Validation of a risk assessment instrument for pulmonary arterial hypertension

    Article • European Heart Journal, June 2017, Oxford University Press (OUP)

    Professor Marc Humbert, Professor Olivier SITBON

  102. Pulmonary hypertension due to left heart disease

    Article • Archives of Cardiovascular Diseases, June 2017, Elsevier

    Professor Olivier SITBON

  103. Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study

    Article • Archives of Cardiovascular Diseases, May 2017, Elsevier

    Professor Olivier SITBON

  104. Long-term outcomes of pulmonary arterial hypertension under specific drug therapy in Eisenmenger syndrome

    Article • The Journal of Heart and Lung Transplantation, April 2017, Elsevier

    Professor Olivier SITBON

  105. Ambrisentan use for pulmonary arterial hypertension in a post-authorization drug registry: The VOLibris Tracking Study

    Article • The Journal of Heart and Lung Transplantation, April 2017, Elsevier

    Professor Olivier SITBON

  106. Long-term outcome in liver transplantation candidates with portopulmonary hypertension

    Article • Hepatology, March 2017, Wiley

    Professor Olivier SITBON

  107. Gut–Lung Connection in Pulmonary Arterial Hypertension

    Article • American Journal of Respiratory Cell and Molecular Biology, March 2017, American Thoracic Society

    Dr Frédéric Perros, Professor Olivier SITBON

  108. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension

    Article • European Heart Journal, February 2017, Oxford University Press (OUP)

    Professor Nazzareno Galie, Professor Rogerio Souza, Professor Olivier SITBON, Prof Tomas Pulido

  109. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study

    Article • The Lancet Respiratory Medicine, February 2017, Elsevier

    Professor Olivier SITBON

  110. Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience

    Article • European Respiratory Review, January 2017, European Respiratory Society (ERS)

    Professor Olivier SITBON

  111. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension

    Article • CHEST Journal, January 2017, Elsevier

    Professor Rogerio Souza, Professor Olivier SITBON, Prof Tomas Pulido

  112. Proceedings of Réanimation 2017, the French Intensive Care Society International Congress

    Article • Annals of Intensive Care, January 2017, Springer Science + Business Media

    Professor Olivier SITBON

  113. A Clinical and Echocardiographic Score to Identify Pulmonary Hypertension Due to HFpEF

    Article • Journal of Cardiac Failure, January 2017, Elsevier

    Professor Olivier SITBON

  114. Beyond a single pathway: combination therapy in pulmonary arterial hypertension

    Article • European Respiratory Review, November 2016, European Respiratory Society (ERS)

    Olivier Sitbon, Professor Olivier SITBON

  115. BMPR2mutation status influences bronchial vascular changes in pulmonary arterial hypertension

    Article • European Respiratory Journal, November 2016, European Respiratory Society (ERS)

    Professor Olivier SITBON

  116. Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity

    Article • European Respiratory Journal, October 2016, European Respiratory Society (ERS)

    Professor Olivier SITBON

  117. Interferon-induced pulmonary hypertension

    Article • Current Opinion in Pulmonary Medicine, September 2016, Wolters Kluwer Health

    Professor Olivier SITBON

  118. Pulmonary arterial hypertension in idiopathic inflammatory myopathies

    Article • Medicine, September 2016, Wolters Kluwer Health

    Professor Olivier SITBON

  119. Non-invasive diagnosis of pulmonary hypertension from lung Doppler signal: a proof of concept study

    Article • Journal of Clinical Monitoring and Computing, August 2016, Springer Science + Business Media

    Professor Olivier SITBON

  120. Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension

    Article • Journal of Clinical Investigation, August 2016, American Society for Clinical Investigation

    Professor Olivier SITBON

  121. Direct-Acting Antiviral Medications for Hepatitis C Virus Infection and Pulmonary Arterial Hypertension

    Article • CHEST Journal, July 2016, Elsevier

    Professor Olivier SITBON

  122. International Liver Transplant Society Practice Guidelines

    Article • Transplantation, July 2016, Wolters Kluwer Health

    Professor Olivier SITBON

  123. Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension

    Article • CHEST Journal, June 2016, Elsevier

    Professor Olivier SITBON

  124. Lung capillary blood volume and membrane diffusion in precapillary pulmonary hypertension

    Article • The Journal of Heart and Lung Transplantation, May 2016, Elsevier

    Professor Olivier SITBON

  125. Response to Letter Regarding Article, “Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model”

    Article • Circulation, April 2016, Wolters Kluwer Health

    Professor Olivier SITBON

  126. Diagnostic concordance of different criteria for exercise pulmonary hypertension in subjects with normal resting pulmonary artery pressure

    Article • European Respiratory Journal, March 2016, European Respiratory Society (ERS)

    Professor Olivier SITBON

  127. Pulmonary veno-occlusive disease

    Article • European Respiratory Journal, March 2016, European Respiratory Society (ERS)

    Professor Marc Humbert, Professor Olivier SITBON

  128. Initial dual oral combination therapy in pulmonary arterial hypertension

    Article • European Respiratory Journal, March 2016, European Respiratory Society (ERS)

    Olivier Sitbon, Professor Olivier SITBON

  129. Resting pulmonary artery pressure of 21–24 mmHg predicts abnormal exercise haemodynamics

    Article • European Respiratory Journal, March 2016, European Respiratory Society (ERS)

    Professor Olivier SITBON

  130. A rare case of sarcoidosis-associated pulmonary hypertension in a patient exposed to silica

    Article • European Respiratory Review, February 2016, European Respiratory Society (ERS)

    Professor Olivier SITBON

  131. Patients’, relatives’, and practitioners’ views of pulmonary arterial hypertension: A qualitative study

    Article • La Presse Médicale, February 2016, Elsevier

    Professor Olivier SITBON

  132. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis

    Article • The Lancet Respiratory Medicine, February 2016, Elsevier

    Professor Olivier SITBON, Dr. Erika Berman Rosenzweig, Professor Zhi-Cheng JING

  133. Loss of Vascular Distensibility During Exercise Is an Early Hemodynamic Marker of Pulmonary Vascular Disease

    Article • CHEST Journal, February 2016, Elsevier

    Professor Olivier SITBON

  134. Comparative Safety and Tolerability of Prostacyclins in Pulmonary Hypertension

    Article • Drug Safety, January 2016, Springer Science + Business Media

    Professor Olivier SITBON

  135. Kinetics of Cardiac Output at the Onset of Exercise in Precapillary Pulmonary Hypertension

    Article • BioMed Research International, January 2016, Hindawi Publishing Corporation

    Professor Olivier SITBON

  136. Infections liées aux cathéters veineux centraux tunnélisés chez les patients ayant une hypertension artérielle pulmonaire traitée par prostacycline intraveineuse

    Article • La Presse Médicale, January 2016, Elsevier

    Professor Olivier SITBON

  137. Selexipag for the Treatment of Pulmonary Arterial Hypertension

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 2015, New England Journal of Medicine (NEJM/MMS)

    Professor Olivier SITBON, Horst Olschewski

  138. Genetic counselling in a national referral centre for pulmonary hypertension

    Article • European Respiratory Journal, December 2015, European Respiratory Society (ERS)

    Professor Olivier SITBON

  139. Usefulness of Cardiovascular Magnetic Resonance Indices to Rule In or Rule Out Precapillary Pulmonary Hypertension

    Article • Canadian Journal of Cardiology, December 2015, Elsevier

    Professor Rogerio Souza, Professor Olivier SITBON

  140. Chronic thromboembolic pulmonary hypertension

    Article • La Presse Médicale, December 2015, Elsevier

    Professor Olivier SITBON

  141. Pulmonary arterial hypertension in patients treated with interferon: TABLE 1

    Article • European Respiratory Journal, November 2015, European Respiratory Society (ERS)

    Professor Olivier SITBON

  142. Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease

    Article • European Respiratory Journal, November 2015, European Respiratory Society (ERS)

    Pr David Montani, Professor Olivier SITBON

  143. Pulmonary Hypertension Complicating Fibrosing Mediastinitis

    Article • Medicine, November 2015, Wolters Kluwer Health

    Professor Olivier SITBON

  144. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN

    Article • European Respiratory Journal, October 2015, European Respiratory Society (ERS)

    Professor Rogerio Souza, Professor Olivier SITBON

  145. The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress

    Article • European Respiratory Journal, September 2015, European Respiratory Society (ERS)

    Andrew Peacock, Professor Olivier SITBON

  146. Response to Letter Regarding Article, “Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension”

    Article • Circulation, September 2015, Wolters Kluwer Health

    Professor Olivier SITBON

  147. Mitomycin-Induced Pulmonary Veno-Occlusive Disease

    Article • Circulation, September 2015, Wolters Kluwer Health

    Professor Olivier SITBON

  148. A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension

    Article • Annals of the Rheumatic Diseases, August 2015, BMJ

    Professor Olivier SITBON

  149. New pharmacotherapy options for pulmonary arterial hypertension

    Article • Expert Opinion on Pharmacotherapy, August 2015, Informa Healthcare

    Professor Olivier SITBON

  150. Non-Invasive Determination of Cardiac Output in Pre-Capillary Pulmonary Hypertension

    Article • PLOS One, July 2015, PLOS

    Professor Olivier SITBON

  151. Nasal decongestant exposure in patients with pulmonary arterial hypertension: a pilot study: TABLE 1

    Article • European Respiratory Journal, July 2015, European Respiratory Society (ERS)

    Marie-Camille Chaumais, Professor Olivier SITBON

  152. Criteria for diagnosis of exercise pulmonary hypertension

    Article • European Respiratory Journal, May 2015, European Respiratory Society (ERS)

    Professor Olivier SITBON

  153. Characteristics of Pulmonary Arterial Hypertension in Affected Carriers of a Mutation Located in the Cytoplasmic Tail of Bone Morphogenetic Protein Receptor Type 2

    Article • CHEST Journal, May 2015, Elsevier

    Professor Olivier SITBON

  154. Inspiratory muscle function, dynamic hyperinflation and exertional dyspnoea in pulmonary arterial hypertension

    Article • European Respiratory Journal, April 2015, European Respiratory Society (ERS)

    Professor Olivier SITBON

  155. Validation of two predictive models for survival in pulmonary arterial hypertension

    Article • European Respiratory Journal, April 2015, European Respiratory Society (ERS)

    Olivier Sitbon, Professor Olivier SITBON

  156. Systolic and Mean Pulmonary Artery Pressures

    Article • CHEST Journal, April 2015, Elsevier

    Professor Olivier SITBON

  157. Relation between left ventricular ejection time and pulmonary hemodynamics in pulmonary hypertension

    Article • International Journal of Cardiology, April 2015, Elsevier

    Professor Olivier SITBON

  158. Chemotherapy-Induced Pulmonary Hypertension

    Article • American Journal Of Pathology, February 2015, Elsevier

    Professor Olivier SITBON

  159. Effect of Macitentan on Hospitalizations

    Article • JACC Heart Failure, January 2015, Elsevier

    Professor Rogerio Souza, Professor Olivier SITBON

  160. Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension

    Article • Circulation, December 2014, Wolters Kluwer Health

    Professor Olivier SITBON

  161. Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment

    Article • European Respiratory Review, December 2014, European Respiratory Society (ERS)

    Professor Olivier SITBON

  162. Pulmonary arterial hypertension

    Article • December 2014, European Respiratory Society (ERS)

    Professor Olivier SITBON

  163. Clinical Pharmacology of Endothelin Receptor Antagonists Used in the Treatment of Pulmonary Arterial Hypertension

    Article • American Journal of Cardiovascular Drugs, November 2014, Springer Science + Business Media

    Professor Olivier SITBON

  164. Pulmonary arterial hypertension in patients treated with interferon

    Article • European Respiratory Journal, October 2014, European Respiratory Society (ERS)

    Professor Olivier SITBON

  165. Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group

    Article • La Presse Médicale, October 2014, Elsevier

    Professor Olivier SITBON

  166. Hypertension pulmonaire et maladies hépatiques

    Article • La Presse Médicale, September 2014, Elsevier

    Professor Olivier SITBON

  167. Traitement chirurgical de l’hypertension pulmonaire post-embolique

    Article • La Presse Médicale, September 2014, Elsevier

    Professor Olivier SITBON

  168. Traitement de l’hypertension artérielle pulmonaire

    Article • La Presse Médicale, September 2014, Elsevier

    Professor Olivier SITBON

  169. Mechanisms of exertional dyspnoea in pulmonary veno-occlusive disease with EIF2AK4 mutations

    Article • European Respiratory Journal, August 2014, European Respiratory Society (ERS)

    Professor Olivier SITBON

  170. Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension

    Article • The Journal of Heart and Lung Transplantation, July 2014, Elsevier

    Professor Olivier SITBON

  171. Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension

    Article • European Respiratory Journal, May 2014, European Respiratory Society (ERS)

    Christine Selton-Suty, Professor Olivier SITBON

  172. The potential for macitentan, a new dual endothelin receptor antagonist, in the treatment of pulmonary arterial hypertension

    Article • Therapeutic Advances in Respiratory Disease, April 2014, SAGE Publications

    Professor Olivier SITBON

  173. Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: Data from the French pulmonary hypertension registry

    Article • International Journal of Cardiology, April 2014, Elsevier

    Professor Olivier SITBON

  174. Biomarkers for the prognosis of pulmonary arterial hypertension: Holy grail or flying circus?

    Article • The Journal of Heart and Lung Transplantation, April 2014, Elsevier

    Professor Olivier SITBON

  175. Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study

    Article • European Respiratory Journal, March 2014, European Respiratory Society (ERS)

    Professor Olivier SITBON

  176. EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension

    Article • American Heart Journal, February 2014, Elsevier

    Olivier Sitbon, Professor Olivier SITBON

  177. Right heart failure: Toward a common language

    Article • The Journal of Heart and Lung Transplantation, February 2014, Elsevier

    Professor Olivier SITBON

  178. Targeted therapies in pulmonary arterial hypertension

    Article • Pharmacology & Therapeutics, February 2014, Elsevier

    Professor Olivier SITBON

  179. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension

    Article • Nature Genetics, December 2013, Springer Science + Business Media

    Professor Damien Bonnet, Professor Olivier SITBON

  180. Treatment Goals of Pulmonary Hypertension

    Article • Journal of the American College of Cardiology, December 2013, Elsevier

    Professor Olivier SITBON

  181. Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension

    Article • European Respiratory Journal, November 2013, European Respiratory Society (ERS)

    Professor Olivier SITBON

  182. Left Ventricular Ejection Time in Acute Heart Failure Complicating Precapillary Pulmonary Hypertension

    Article • CHEST Journal, November 2013, Elsevier

    Professor Olivier SITBON

  183. Pulmonary arterial hypertension in familial hemiplegic migraine with ATP1A2 channelopathy

    Article • European Respiratory Journal, October 2013, European Respiratory Society (ERS)

    Professor Olivier SITBON

  184. Inflammatory Mechanisms in HIV-Associated Pulmonary Arterial Hypertension

    Article • Seminars in Respiratory and Critical Care Medicine, September 2013, Thieme Publishing Group

    Professor Olivier SITBON

  185. Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2013, New England Journal of Medicine (NEJM/MMS)

    Professor Rogerio Souza, Professor Olivier SITBON, Professor Zhi-Cheng JING

  186. Pharmacokinetic evaluation of sildenafil as a pulmonary hypertension treatment

    Article • Expert Opinion on Drug Metabolism & Toxicology, June 2013, Informa Healthcare

    Professor Olivier SITBON

  187. Pulmonary arterial hypertension

    Article • Orphanet Journal of Rare Diseases, January 2013, Springer Science + Business Media

    Professor Olivier SITBON

  188. Calcium-Channel Blockers in Pulmonary Arterial Hypertension

    Article • January 2013, Springer Science + Business Media

    Professor Olivier SITBON

  189. Pathways in pulmonary arterial hypertension: the future is here

    Article • European Respiratory Review, November 2012, European Respiratory Society (ERS)

    Professor Olivier SITBON

  190. Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era

    Article • Annals of the Rheumatic Diseases, November 2012, BMJ

    Professor Olivier SITBON

  191. Independent Association of Urinary F2-Isoprostanes With Survival in Pulmonary Arterial Hypertension

    Article • CHEST Journal, October 2012, Elsevier

    Dr Denis Monneret, Professor Olivier SITBON

  192. Pulmonary veno-occlusive disease and pulmonary capillary haemangiomatosis

    Article • September 2012, European Respiratory Society (ERS)

    Professor Olivier SITBON

  193. Hemodynamics in Pulmonary Arterial Hypertension: Current and Future Perspectives

    Article • The American Journal of Cardiology, September 2012, Elsevier

    Professor Olivier SITBON

  194. The study of risk in pulmonary arterial hypertension

    Article • European Respiratory Review, August 2012, European Respiratory Society (ERS)

    Professor Olivier SITBON

  195. Treat-to-target approach in pulmonary arterial hypertension: a consensus-based proposal

    Article • European Respiratory Review, August 2012, European Respiratory Society (ERS)

    Professor Olivier SITBON

  196. Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension

    Article • Arthritis & Rheumatism, August 2012, Wiley

    Professor Olivier SITBON

  197. Renal Replacement Therapy in Patients with Severe Precapillary Pulmonary Hypertension with Acute Right Heart Failure

    Article • Respiration, August 2012, Karger Publishers

    Professor Olivier SITBON

  198. Out-of-Proportion Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction

    Article • Respiration, August 2012, Karger Publishers

    Professor Olivier SITBON

  199. Dynamic respiratory mechanics and exertional dyspnoea in pulmonary arterial hypertension

    Article • European Respiratory Journal, July 2012, European Respiratory Society (ERS)

    Professor Olivier SITBON

  200. EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism: Figure 1–

    Article • European Respiratory Journal, May 2012, European Respiratory Society (ERS)

    Professor Olivier SITBON

  201. Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension

    Article • European Respiratory Journal, May 2012, European Respiratory Society (ERS)

    Professor Olivier SITBON

  202. Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

    Article • Circulation, May 2012, Wolters Kluwer Health

    Professor Olivier SITBON

  203. Mediastinal Fibrosis Mimicking Proximal Chronic Thromboembolic Disease

    Article • Circulation, April 2012, Wolters Kluwer Health

    Professor Olivier SITBON

  204. Pulmonary hypertension associated with benfluorex exposure

    Article • European Respiratory Journal, April 2012, European Respiratory Society (ERS)

    Professor Olivier SITBON

  205. Portopulmonary Hypertension

    Article • CHEST Journal, April 2012, Elsevier

    Professor Olivier SITBON

  206. L’hypertension artérielle pulmonaire associée au VIH

    Article • Revue des Maladies Respiratoires, April 2012, Elsevier

    Professor Olivier SITBON

  207. Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: An observational study

    Article • The Journal of Heart and Lung Transplantation, February 2012, Elsevier

    Professor Olivier SITBON

  208. Portopulmonary Hypertension and Hepatopulmonary Syndrome

    Article • January 2012, Karger Publishers

    Professor Olivier SITBON

  209. Optimal management of severe pulmonary arterial hypertension

    Article • European Respiratory Review, November 2011, European Respiratory Society (ERS)

    Professor Olivier SITBON

  210. Systemic lupus erythematosus-associated PAH: is targeting inflammation the key to success?

    Article • European Respiratory Review, November 2011, European Respiratory Society (ERS)

    Professor Olivier SITBON

  211. Ventilation/perfusion lung scan in pulmonary veno-occlusive disease

    Article • European Respiratory Journal, November 2011, European Respiratory Society (ERS)

    Professor Olivier SITBON

  212. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival

    Article • Arthritis & Rheumatism, October 2011, Wiley

    Professor Olivier SITBON

  213. Pulmonary Arterial Hypertension in a Patient With Cowden Syndrome and Anorexigen Exposure

    Article • CHEST Journal, October 2011, Elsevier

    Professor Olivier SITBON

  214. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies

    Article • Arthritis & Rheumatism, August 2011, Wiley

    Dr Stephen C Mathai, Professor Olivier SITBON

  215. Treatment of pulmonary arterial hypertension with targeted therapies

    Article • Nature Reviews Cardiology, July 2011, Springer Science + Business Media

    Professor Olivier SITBON

  216. The association between resting and mild-to-moderate exercise pulmonary artery pressure

    Article • European Respiratory Journal, July 2011, European Respiratory Society (ERS)

    Professor Olivier SITBON

  217. Pulmonary hypertension related to appetite suppressants

    Article • May 2011, Taylor & Francis

    Professor Olivier SITBON

  218. Pulmonary Hypertension in Patients With Neurofibromatosis Type I

    Article • Medicine, May 2011, Wolters Kluwer Health

    Professor Olivier SITBON

  219. Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension

    Article • Expert Opinion on Pharmacotherapy, April 2011, Informa Healthcare

    Professor Olivier SITBON

  220. Prise en charge de l’hypertension artérielle pulmonaire en 2011 : les innovations depuis les recommandations ERS/ESC 2009

    Article • La Presse Médicale, April 2011, Elsevier

    Professor Olivier SITBON

  221. Pulmonary veno-occlusive disease: The bête noire of pulmonary hypertension in connective tissue diseases?

    Article • La Presse Médicale, January 2011, Elsevier

    Professor Olivier SITBON

  222. Current management approaches to portopulmonary hypertension

    Article • International Journal of Clinical Practice, December 2010, Wiley

    Professor Olivier SITBON

  223. Pulmonary arterial hypertension: combination therapy in the modern management era

    Article • European Respiratory Review, November 2010, European Respiratory Society (ERS)

    Professor Olivier SITBON

  224. Treat-to-target strategies in pulmonary arterial hypertension: the importance of using multiple goals

    Article • European Respiratory Review, November 2010, European Respiratory Society (ERS)

    Professor Olivier SITBON

  225. Pharmacokinetic evaluation of continuous intravenous epoprostenol

    Article • Expert Opinion on Drug Metabolism & Toxicology, November 2010, Informa Healthcare

    Professor Olivier SITBON

  226. Effects of HIV Protease Inhibitors on Progression of Monocrotaline- and Hypoxia-Induced Pulmonary Hypertension in Rats

    Article • Circulation, November 2010, Wolters Kluwer Health

    Professor Olivier SITBON

  227. Evidence for the use of combination targeted therapeutic approaches for the management of pulmonary arterial hypertension

    Article • Respiratory Medicine, July 2010, Elsevier

    Professor Olivier SITBON

  228. Pulmonary veno-occlusive disease: Recent progress and current challenges

    Article • Respiratory Medicine, July 2010, Elsevier

    Professor Olivier SITBON

  229. Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

    Article • Circulation, June 2010, Wolters Kluwer Health

    Professor Rogerio Souza, Professor Olivier SITBON

  230. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension

    Article • European Respiratory Journal, June 2010, European Respiratory Society (ERS)

    Professor Rogerio Souza, Professor Olivier SITBON, Professor Zhi-Cheng JING

  231. Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension

    Article • European Heart Journal, June 2010, European Society of Cardiology

    Professor Olivier SITBON

  232. Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension

    Article • June 2010, Springer Science + Business Media

    Professor Olivier SITBON

  233. Objectifs thérapeutiques dans l’hypertension artérielle pulmonaire

    Article • La Presse Médicale, June 2010, Elsevier

    Professor Olivier SITBON

  234. Characterization of Pulmonary Arterial Hypertension Patients Walking More Than 450 m in 6 Min at Diagnosis

    Article • CHEST Journal, June 2010, Elsevier

    Professor Olivier SITBON

  235. Assessing effectiveness of pulmonary arterial hypertension therapies in daily practice

    Article • Current Opinion in Pulmonary Medicine, May 2010, Wolters Kluwer Health

    Professor Olivier SITBON

  236. Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying anACVRL1(ALK1) Mutation

    Article • American Review of Respiratory Disease, April 2010, American Thoracic Society

    Professor Olivier SITBON

  237. Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome

    Article • Rheumatology, February 2010, Oxford University Press (OUP)

    Professor Olivier SITBON

  238. Diagnostic et prise en charge de l’hypertension pulmonaire en 2009. Commentaires sur les nouvelles recommandations de l’European Society of Cardiology (ESC) et de l’European Respiratory Society (ERS)

    Article • Revue des Maladies Respiratoires, February 2010, Elsevier

    Professor Olivier SITBON

  239. HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era

    Article • AIDS, January 2010, Wolters Kluwer Health

    Professor Olivier SITBON

  240. Maladie veino-occlusive et hémangiomatose capillaire pulmonaire

    Article • La Presse Médicale, January 2010, Elsevier

    Professor Olivier SITBON

  241. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil

    Article • Rheumatology, December 2009, Oxford University Press (OUP)

    Professor Olivier SITBON

  242. Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre

    Article • European Respiratory Review, November 2009, European Respiratory Society (ERS)

    Professor Olivier SITBON

  243. Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension

    Article • European Respiratory Journal, November 2009, European Respiratory Society (ERS)

    Professor Rogerio Souza, Professor Olivier SITBON

  244. Noncardiothoracic nonobstetric surgery in mild-to-moderate pulmonary hypertension

    Article • European Respiratory Journal, November 2009, European Respiratory Society (ERS)

    Professor Olivier SITBON

  245. Is Pulmonary Arterial Hypertension Really a Late Complication of Systemic Sclerosis?

    Article • CHEST Journal, November 2009, Elsevier

    Professor Olivier SITBON

  246. Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution

    Article • European Respiratory Journal, October 2009, European Respiratory Society (ERS)

    Professor Olivier SITBON

  247. Pulmonary Venoocclusive Disease and Failure of Specific Therapy

    Article • CHEST Journal, October 2009, Elsevier

    Professor Olivier SITBON

  248. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension

    Article • Advances in Therapy, September 2009, Springer Science + Business Media

    Professor Olivier SITBON

  249. Fatal dissection of the pulmonary artery in pulmonary arterial hypertension

    Article • European Respiratory Review, August 2009, European Respiratory Society (ERS)

    Professor Olivier SITBON

  250. Idiopathic Pulmonary Arterial Hypertension and Pulmonary Veno-occlusive Disease: Similarities and Differences

    Article • Seminars in Respiratory and Critical Care Medicine, July 2009, Thieme Publishing Group

    Professor Olivier SITBON

  251. Pulmonary Arterial Hypertension and HIV Infection

    Article • Seminars in Respiratory and Critical Care Medicine, July 2009, Thieme Publishing Group

    Professor Olivier SITBON

  252. Intravenous iloprost for pulmonary arterial hypertension: still waiting for evidence

    Article • European Respiratory Journal, June 2009, European Respiratory Society (ERS)

    Professor Olivier SITBON

  253. Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease

    Article • European Respiratory Journal, June 2009, European Respiratory Society (ERS)

    Professor Olivier SITBON

  254. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France

    Article • Arthritis & Rheumatism, June 2009, Wiley

    Professor Olivier SITBON, Christine Selton-Suty

  255. End Points and Clinical Trial Design in Pulmonary Arterial Hypertension

    Article • Journal of the American College of Cardiology, June 2009, Elsevier

    Professor Olivier SITBON

  256. Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension

    Article • Journal of the American College of Cardiology, June 2009, Elsevier

    Professor Olivier SITBON

  257. Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats

    Article • European Respiratory Journal, March 2009, European Respiratory Society (ERS)

    Professor Olivier SITBON

  258. Fenfluramine-like cardiovascular side-effects of benfluorex

    Article • European Respiratory Journal, February 2009, European Respiratory Society (ERS)

    Professor Olivier SITBON

  259. Pulmonary veno-occlusive disease

    Article • European Respiratory Journal, January 2009, European Respiratory Society (ERS)

    Professor Olivier SITBON

  260. Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension

    Article • European Respiratory Journal, January 2009, European Respiratory Society (ERS)

    Professor Olivier SITBON

  261. Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension

    Article • Annals of Internal Medicine, October 2008, American College of Physicians

    Professor Olivier SITBON

  262. Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinerAIR-Sclerodermie study

    Article • Rheumatology, October 2008, Oxford University Press (OUP)

    Professor Olivier SITBON, Christine Selton-Suty

  263. Portopulmonary Hypertension

    Article • American Review of Respiratory Disease, September 2008, American Thoracic Society

    Professor Rogerio Souza, Professor Olivier SITBON

  264. HIV-related pulmonary arterial hypertension: clinical presentation and management

    Article • AIDS, September 2008, Wolters Kluwer Health

    Professor Olivier SITBON

  265. Review: Therapeutic advances in pulmonary arterial hypertension

    Article • Therapeutic Advances in Respiratory Disease, August 2008, SAGE Publications

    Professor Olivier SITBON

  266. Pulmonary Veno-Occlusive Disease

    Article • Medicine, July 2008, Wolters Kluwer Health

    Professor Olivier SITBON

  267. Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers ofBMPR2Mutation

    Article • American Review of Respiratory Disease, June 2008, American Thoracic Society

    Professor Rogerio Souza, Professor Olivier SITBON

  268. Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension

    Article • European Respiratory Journal, March 2008, European Respiratory Society (ERS)

    Professor Olivier SITBON

  269. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases

    Article • European Respiratory Journal, February 2008, European Respiratory Society (ERS)

    Professor Rogerio Souza, Professor Olivier SITBON

  270. Immunosuppressive therapy in lupus- and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases

    Article • Arthritis & Rheumatism, January 2008, Wiley

    Professor Olivier SITBON

  271. Prevalence of HIV-related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era

    Article • American Review of Respiratory Disease, January 2008, American Thoracic Society

    Professor Olivier SITBON

  272. Intravenous Epoprostenol in Inoperable Chronic Thromboembolic Pulmonary Hypertension

    Article • The Journal of Heart and Lung Transplantation, April 2007, Elsevier

    Professor Rogerio Souza, Professor Olivier SITBON

  273. Hypertension pulmonaire postembolique

    Article • Revue des Maladies Respiratoires, April 2007, Elsevier

    Professor Olivier SITBON

  274. Hypertension artérielle pulmonaire postembolique tumorale

    Article • Revue des Maladies Respiratoires, March 2007, Elsevier

    Professor Olivier SITBON

  275. Pulmonary vascular abnormalities in cirrhosis

    Article • Best Practice & Research Clinical Gastroenterology, January 2007, Elsevier

    Professor Olivier SITBON

  276. Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension

    Article • Journal of Cardiovascular Pharmacology, January 2007, Wolters Kluwer Health

    Professor Olivier SITBON

  277. Hypertension portopulmonaire

    Article • Revue des Maladies Respiratoires, December 2006, Elsevier

    Professor Olivier SITBON

  278. Cœur pulmonaire chronique postembolique révélant une bêtathalassémie intermédiaire après splénectomie

    Article • La Revue de Médecine Interne, December 2006, Elsevier

    Professor Olivier SITBON

  279. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects

    Article • European Journal of Clinical Investigation, September 2006, Wiley

    Professor Olivier SITBON

  280. Long term imatinib treatment in pulmonary arterial hypertension

    Article • Thorax, August 2006, BMJ

    Professor Rogerio Souza, Professor Olivier SITBON

  281. Immunosuppressive Therapy in Connective Tissue Diseases-Associated Pulmonary Arterial Hypertension

    Article • CHEST Journal, July 2006, Elsevier

    Professor Olivier SITBON

  282. Pulmonary Arterial Hypertension in France

    Article • American Review of Respiratory Disease, May 2006, American Thoracic Society

    Professor Olivier SITBON

  283. Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension

    Article • Human Mutation, February 2006, Wiley

    Professor Olivier SITBON, Horst Olschewski

  284. Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension

    Article • European Heart Journal, January 2006, European Society of Cardiology

    Professor Olivier SITBON

  285. Deleterious Effects of β-Blockers on Exercise Capacity and Hemodynamics in Patients With Portopulmonary Hypertension

    Article • Gastroenterology, January 2006, Elsevier

    Professor Olivier SITBON

  286. Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension

    Article • European Respiratory Journal, January 2006, European Respiratory Society (ERS)

    Professor Olivier SITBON

  287. Occult alveolar haemorrhage in pulmonary veno-occlusive disease

    Article • European Respiratory Journal, January 2006, European Respiratory Society (ERS)

    Professor Olivier SITBON

  288. Clinical Challenges in Pulmonary Hypertension

    Article • CHEST Journal, December 2005, Elsevier

    Professor Olivier SITBON

  289. Pulmonary Endothelin-1 Clearance in Human Pulmonary Arterial Hypertension

    Article • CHEST Journal, December 2005, Elsevier

    Professor Olivier SITBON

  290. Splenectomy and chronic thromboembolic pulmonary hypertension

    Article • Thorax, December 2005, BMJ

    Professor Olivier SITBON

  291. Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol

    Article • Thorax, December 2005, BMJ

    Professor Olivier SITBON

  292. Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease

    Article • European Respiratory Journal, November 2005, European Respiratory Society (ERS)

    Professor Olivier SITBON

  293. Diagnostic et classification des hypertensions artérielles pulmonaires

    Article • La Presse Médicale, November 2005, Elsevier

    Professor Olivier SITBON

  294. Génétique de l’hypertension artérielle pulmonaire: données récentes et applications pratiques

    Article • Revue des Maladies Respiratoires, November 2005, Elsevier

    Professor Olivier SITBON

  295. Traitement chirurgical de la maladie thromboembolique pulmonaire chronique

    Article • La Presse Médicale, November 2005, Elsevier

    Professor Olivier SITBON

  296. Les traitements de l’hypertension artérielle pulmonaire à l’heure de la T2A. Recommandations du groupe de travail “Maladies vasculaires pulmonaires” de la Société de pneumologie de langue française

    Article • La Presse Médicale, November 2005, Elsevier

    Professor Olivier SITBON

  297. Traitement de l’hypertension artérielle pulmonaire

    Article • La Presse Médicale, November 2005, Elsevier

    Professor Olivier SITBON

  298. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis

    Article • Thorax, October 2005, BMJ

    Professor Olivier SITBON

  299. Hypertension artérielle pulmonaire

    Article • Revue des Maladies Respiratoires, September 2005, Elsevier

    Professor Olivier SITBON

  300. Human herpes virus 8 in HIV and non-HIV infected patients with pulmonary arterial hypertension in France

    Article • AIDS, July 2005, Wolters Kluwer Health

    Professor Olivier SITBON

  301. Treatment of pulmonary arterial hypertension with bosentan: from pathophysiology to clinical evidence

    Article • Expert Opinion on Pharmacotherapy, July 2005, Informa Healthcare

    Professor Olivier SITBON

  302. Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension

    Article • Circulation, June 2005, Wolters Kluwer Health

    Professor Olivier SITBON

  303. Severe Pulmonary Hypertension during Pregnancy

    Article • Anesthesiology, June 2005, Wolters Kluwer Health

    Professor Olivier SITBON

  304. Bosentan therapy for pulmonary arterial hypertension

    Article • Future Cardiology, May 2005, Future Medicine

    Professor Olivier SITBON

  305. Survival with first-line bosentan in patients with primary pulmonary hypertension

    Article • European Respiratory Journal, February 2005, European Respiratory Society (ERS)

    Professor Olivier SITBON

  306. Évaluation pronostique de biomarqueurs dans l’hypertension artérielle pulmonaire

    Article • Revue des Maladies Respiratoires, December 2004, Elsevier

    Professor Olivier SITBON

  307. Bosentan for the Treatment of Human Immunodeficiency Virus–associated Pulmonary Arterial Hypertension

    Article • American Review of Respiratory Disease, December 2004, American Thoracic Society

    Professor Olivier SITBON

  308. Caractéristiques cliniques, hémodynamiques et génétiques de l’hypertension artérielle pulmonaire familiale

    Article • Revue des Maladies Respiratoires, November 2004, Elsevier

    Professor Olivier SITBON

  309. Traitement de l'hypertension artérielle pulmonaire

    Article • La Revue de Médecine Interne, October 2004, Elsevier

    Professor Olivier SITBON

  310. Treatment of Pulmonary Arterial Hypertension

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2004, New England Journal of Medicine (NEJM/MMS)

    Professor Olivier SITBON

  311. Pulmonary Hypertension:CT of the Chest in Pulmonary Venoocclusive Disease

    Article • American Journal of Roentgenology, July 2004, American Roentgen Ray Society

    Professor Olivier SITBON

  312. Diagnosis and differential assessment of pulmonary arterial hypertension

    Article • Journal of the American College of Cardiology, June 2004, Elsevier

    Professor Olivier SITBON, Horst Olschewski

  313. Endothelin receptor antagonists in pulmonary arterial hypertension

    Article • Journal of the American College of Cardiology, June 2004, Elsevier

    Professor Olivier SITBON

  314. Prostanoid therapy for pulmonary arterial hypertension

    Article • Journal of the American College of Cardiology, June 2004, Elsevier

    Professor Olivier SITBON, Horst Olschewski

  315. Prise en charge thérapeutique de l’hypertension porto-pulmonaire

    Article • Revue des Maladies Respiratoires, June 2004, Elsevier

    Professor Olivier SITBON

  316. Automatic quantification of right ventricular function with gated blood pool SPECT

    Article • Journal of Nuclear Cardiology, May 2004, Springer Science + Business Media

    Professor Olivier SITBON

  317. Chronic thromboembolic pulmonary hypertension

    Article • European Respiratory Journal, April 2004, European Respiratory Society (ERS)

    Professor Olivier SITBON

  318. Traitement chirurgical de l’hypertension artérielle pulmonaire post-embolique

    Article • Revue de Pneumologie Clinique, April 2004, Elsevier

    Professor Olivier SITBON

  319. Prise en charge thérapeutique de l’hypertension porto-pulmonaire

    Article • Gastroentérologie Clinique et Biologique, April 2004, Elsevier

    Professor Olivier SITBON

  320. Novel therapeutic perspectives in pulmonary arterial hypertension

    Article • European Respiratory Journal, August 2003, European Respiratory Society (ERS)

    Professor Olivier SITBON

  321. Effects of the Dual Endothelin Receptor Antagonist Bosentan in Patients With Pulmonary Arterial Hypertension

    Article • CHEST Journal, July 2003, Elsevier

    Professor Olivier SITBON

  322. Prognostic Factors for Survival in Human Immunodeficiency Virus–associated Pulmonary Arterial Hypertension

    Article • American Review of Respiratory Disease, May 2003, American Thoracic Society

    Professor Olivier SITBON

  323. BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives

    Article • European Respiratory Journal, September 2002, European Respiratory Society (ERS)

    Professor Olivier SITBON

  324. Primary pulmonary hypertension: Current therapy

    Article • Progress in Cardiovascular Diseases, September 2002, Elsevier

    Professor Olivier SITBON

  325. Inhaled Iloprost for Severe Pulmonary Hypertension

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2002, New England Journal of Medicine (NEJM/MMS)

    Professor Olivier SITBON, Horst Olschewski

  326. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension

    Article • Journal of the American College of Cardiology, August 2002, Elsevier

    Professor Olivier SITBON

  327. Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis

    Article • European Respiratory Journal, July 2002, European Respiratory Society (ERS)

    Professor Olivier SITBON

  328. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial

    Article • Journal of the American College of Cardiology, May 2002, Elsevier

    Professor Olivier SITBON

  329. Pulmonary Arterial Hypertension: Thin-Section CT Predictors of Epoprostenol Therapy Failure

    Article • Radiology, March 2002, Radiological Society of North America (RSNA)

    Professor Olivier SITBON

  330. Pulmonary Artery Pressure–Flow Relations after Prostacyclin in Primary Pulmonary Hypertension

    Article • American Review of Respiratory Disease, February 2002, American Thoracic Society

    Professor Olivier SITBON

  331. Hypertension artérielle pulmonaire associée aux connectivites

    Article • La Revue de Médecine Interne, January 2002, Elsevier

    Professor Olivier SITBON

  332. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

    Article • The Lancet, October 2001, Elsevier

    Professor Olivier SITBON

  333. PATHOBIOLOGY OF PULMONARY HYPERTENSION

    Article • Clinics in Chest Medicine, September 2001, Elsevier

    Professor Olivier SITBON

  334. RISK FACTORS FOR PULMONARY ARTERIAL HYPERTENSION

    Article • Clinics in Chest Medicine, September 2001, Elsevier

    Professor Olivier SITBON

  335. Improvement of von Willebrand Factor Proteolysis After Prostacyclin Infusion in Severe Pulmonary Arterial Hypertension

    Article • Circulation, November 2000, Wolters Kluwer Health

    Professor Olivier SITBON

  336. Imbalance between Platelet Vascular Endothelial Growth Factor and Platelet-derived Growth Factor in Pulmonary Hypertension

    Article • American Review of Respiratory Disease, October 2000, American Thoracic Society

    Professor Olivier SITBON

  337. Severe Pulmonary Hypertension in Histiocytosis X

    Article • American Review of Respiratory Disease, January 2000, American Thoracic Society

    Professor Olivier SITBON

  338. Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study

    Article • European Respiratory Journal, June 1999, European Respiratory Society (ERS)

    Professor Olivier SITBON

  339. Treatment of pulmonary hypertension secondary to connective tissue diseases

    Article • Thorax, March 1999, BMJ

    Professor Olivier SITBON

  340. Primary Pulmonary Hypertension Associated With the Use of Fenfluramine Derivatives

    Article • CHEST Journal, September 1998, Elsevier

    Professor Olivier SITBON

  341. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension

    Article • European Respiratory Journal, August 1998, European Respiratory Society (ERS)

    Professor Olivier SITBON

  342. Treatment of Severe Pulmonary Hypertension Secondary to Connective Tissue Diseases With Continuous IV Epoprostenol (Prostacyclin)

    Article • CHEST Journal, July 1998, Elsevier

    Professor Olivier SITBON

  343. Pulmonary vascular disorders in portal hypertension

    Article • European Respiratory Journal, May 1998, European Respiratory Society (ERS)

    Professor Olivier SITBON

  344. Clinical Significance of the Pulmonary Vasodilator Response During Short-term Infusion of Prostacyclin in Primary Pulmonary Hypertension

    Article • Circulation, February 1996, Wolters Kluwer Health

    Professor Olivier SITBON, Professor Anh Tuan Dinh-Xuan

  345. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

    Article • American Review of Respiratory Disease, May 1995, American Thoracic Society

    Professor Olivier SITBON

  346. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

    Article • American Review of Respiratory Disease, February 1995, American Thoracic Society

    Professor Olivier SITBON

  347. Pneumopathie aiguë tipidique

    Article • Archives de Pédiatrie, January 1995, Elsevier

    Professor Olivier SITBON

  348. Minocycline pneumonitis and eosinophilia. A report on eight patients

    Article • Archives of Internal Medicine, July 1994, American Medical Association (AMA)

    Professor Olivier SITBON

  349. Minocycline Pneumonitis and Eosinophilia

    Article • Archives of Internal Medicine, July 1994, American Medical Association (AMA)

    Professor Olivier SITBON

  350. Auranofin in steroid dependent asthma.

    Article • Thorax, November 1992, BMJ

    Professor Olivier SITBON

  351. Prostanoid Treatment for Pulmonary Arterial Hypertension

    Article • Wiley

    Professor Olivier SITBON